Letizia Giardino, Senior Director of Cell Therapy, Early Oncology at AstraZeneca, shared a post on LinkedIn:
“Great to see our latest cell therapy research published in Nature.
When you think about how complex solid tumours are, it puts into perspective just how much effort and collaboration is needed to advance our understanding in this space. It’s encouraging to see progress of armoured CAR T in solid tumours, and it gives me hope that we are moving closer to realising the full curative potential of cell therapy.
Proud to be part of AstraZeneca, where science and patients’ needs continue to drive what we do every day.”